After cannulation, the artery was perfused with 1% BSA Ringers for 20 minutes to wash out any remaining blood cells from the region supplied by the cannulated artery. Perfusion pressure was monitored throughout and flow rate adjusted (between 50 and 100 μL/min) to ensure the perfusion pressure did not exceed 70 mm Hg. This was followed by 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer for 20 minutes. The steps that followed varied depending on the fluorescent probed used and are detailed in separate paragraphs below. Phalloidin was the main molecule used as it binds to cytoskeleton F-actin, which is known to be abundantly present in all cells and allows the distinction between arterioles and venules based on the F-actin and smooth muscle distribution pattern. Lectin was also used to label glycocalyx on the intraluminal side of endothelium. Lectin has the advantage of giving more precise labeling as it generally does not leech into the extraluminal region. Antibodies against endothelial and smooth muscle markers were used on some eyes, mostly in conjunction with phalloidin, to label for junctional protein distribution and for potential smooth muscle contractility.
Four of the eyes were then perfusion labeled over the course of 2 hours using 1 mL 0.05 mM lectin from Triticum vulgaris conjugated with FITC (Sigma L4895; Sigma-Aldrich Pty. Ltd., St. Louis, MO, USA) or tetramethylrhodamine (TRITC; Sigma L5266). Any remaining lectin was washed out from the region by perfusing with 0.1 M phosphate buffer for another 30 minutes. The eyes were then immersion-fixed overnight at 4°C in 4% PFA protected from light.
Eight eyes were perfused with 0.1% Triton X-100 in 0.1 M phosphate buffer for 5 to 7 minutes to induce increased permeability for phalloidin. The residue Triton X-100 was washed out by continuous perfusion of phosphate buffer for another 20 minutes; 0.001 mM phalloidin conjugated to FITC (Sigma P5282) or TRITC (Sigma P1951) was perfused separately through the respective arteries over the course of 2 hours to allow ample time for sufficient labeling. Residue phalloidin was washed out by perfusing phosphate buffer for a further 30 minutes. The globes were then immersion-fixed in 4% PFA overnight in the refrigerator protected from light.
Six eyes were perfusion-labeled using the indirect immunofluorescent protocol. After the 4% PFA fixation step, residue fixatives were washed out from the system by continuous perfusion of 0.1 M phosphate buffer for 20 to 30 minutes. A solution comprising 10% donkey serum, 0.1% Triton X-100, and primary antibodies (1 in 50 dilution) was gradually injected into the cannula over the course of 1.5 hours. Residual primary antibodies were then removed by continuous perfusion of phosphate buffer for 30 minutes. This was followed by gradual injection of the corresponding secondary antibodies tagged with fluorescent probes, together with or without 30 U phalloidin conjugated to Alexa Fluor 647 or 488 (A22287 and A12379; Thermo Fisher Scientific, MA, USA) over the course of 1 hour. Residual fluorescent tagged secondary antibodies and phalloidin were then washed out by continuous perfusion of phosphate buffer for 30 minutes. The globes were then immerse-fixed overnight in 4% PFA in the refrigerator protected from light.
Primary antibodies used included goat anti-VE-Cadherin (SC-6458, six eyes; Thermo Fisher Scientific), rabbit anti-eNOS (ab66127, three eyes; Abcam, Melbourne, Victoria, Australia), rabbit anti-occludin (ab31721, one eye; Abcam), goat anti-αSMA (ab21027, one eye; Abcam), rabbit anti-calponin (ab46794, three eyes; Abcam), rabbit anti-αSMA (ab5694, one eye; Abcam), and rabbit anti-PTYR731 (SAB 4504676, one eye; Sigma-Aldrich Pty. Ltd.).
Secondary antibodies used included donkey anti-goat conjugated with Alexa Fluor 555 (Abcam ab150130), donkey anti-rabbit conjugated with Alexa Fluor 488 (Invitrogen A21206), and donkey anti-mouse conjugated with CF 633 (Sigma SAB4600131). Bis-benzamide (H33258, 1.2 μg/mL; Sigma-Aldrich Corp., St. Louis, MO, USA) was added to aid visualization of cell nuclei.